Back to search
Attenuated Familial Adenomatous Polyposis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Attenuated Familial Adenomatous Polyposis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Attenuated Familial Adenomatous Polyposis trials you may qualify forThis phase IIa trial investigates if giving obeticholic acid (OCA) is safe and has a beneficial effect on the number of polyps in the small bowel and colon in p…
RIPAF (Rete Italiana Poliposi Adenomatosa Familiare) is a national, multicenter observational registry designed to establish a coordinated Italian network for t…
The primary objective of this chart review study is to evaluate the outcomes of subjects with Attenuated Familial Adenomatous Polyposis (AFAP) and Deleterious F…
This phase II trial studies the side effects of erlotinib hydrochloride and how well it works in reducing duodenal polyp burden in patients with familial adenom…
The purpose of this study is to determine in a randomized, placebo-controlled, phase II trial if the combination of sulindac and erlotinib causes a significant…